Novartis announced the company’s financial results for the second quarter and first half of 2020.
Novartis revealed the healthcare and pharma industry has emerged as a desired career destination for tech talent during the COVID-19 pandemic, in the Powerful Pairing research report launched today.
Standing by people with sickle cell disease and their families
COVID-19 is disrupting Africa’s health services – potentially undermining decades of progress on child health.
Together in spirit. Find out how our associates all over the world are joining together to make a difference as we celebrate Pride 2020.
EPIS participants call for all stakeholders to ensure the patient voice is at the heart of the development of digital health solutions
Latest oncology resources and news surrounding Novartis data featured at American Society of Clinical Oncology (ASCO)
A new AI-enabled disease management tool in China aims to improve the lives of millions of patients with heart failure.
Read and download the Annual Review, the Annual Report and Form 20-F, and the Novartis in Society ESG report.
This site is intended for a global audience.